Treatment of the schizophrenia prodrome: is it presently ethical? (Q34322842)

1 August 2017

1 reference

title

Treatment of the schizophrenia prodrome: is it presently ethical? (English)

1 reference

1 August 2017

0 references

0 references

schizophrenic prodrome

1 reference

T Lencz

2

0 references

author name string

B A Cornblatt

series ordinal

1

1 reference

1 August 2017

J M Kane

series ordinal

3

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 August 2001

1 reference

1 August 2017

published in

Schizophrenia Research

1 reference

1 August 2017

volume

51

1 reference

1 August 2017

issue

1

1 reference

1 August 2017

page(s)

31-38

1 reference

West London first-episode study of schizophrenia

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900236-5

7 January 2021

Establishing the onset of psychotic illness

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900236-5

7 January 2021

Neuroleptics: effects on neuropsychological function in chronic schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900236-5

7 January 2021

Putatively psychosis-prone subjects 10 years later

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900236-5

7 January 2021

Single indicator of risk for schizophrenia: probable fact or likely myth?

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900236-5

7 January 2021

Neurobiological findings in early phase schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900236-5

7 January 2021

Impaired attention, genetics, and the pathophysiology of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900236-5

7 January 2021

Attention and clinical symptoms in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900236-5

7 January 2021

Cognitive and behavioral precursors of schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900236-5

7 January 2021

Is there an association between duration of untreated psychosis and 24-month clinical outcome in a first-admission series?

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900236-5

7 January 2021

Attention, memory, and motor skills as childhood predictors of schizophrenia-related psychoses: the New York High-Risk Project.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900236-5

7 January 2021

Early subjective experiences in schizophrenic episodes

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900236-5

7 January 2021

The psychotic hinterlands or the fringes of lunacy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900236-5

7 January 2021

Does risperidone improve verbal working memory in treatment-resistant schizophrenia?

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900236-5

7 January 2021

Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"?

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900236-5

7 January 2021

Delay to first antipsychotic medication in schizophrenia: impact on symptomatology and clinical course of illness

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900236-5

7 January 2021

Epidemiology of Schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900236-5

7 January 2021

Epidemiology of early-onset schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900236-5

7 January 2021

IRAOS: an instrument for the assessment of onset and early course of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900236-5

7 January 2021

Depression, negative symptoms, social stagnation and social decline in the early course of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900236-5

7 January 2021

Untreated initial psychosis: its relation to quality of life and symptom remission in first-episode schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900236-5

7 January 2021

Child development risk factors for adult schizophrenia in the British 1946 birth cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900236-5

7 January 2021

The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900236-5

7 January 2021

The risk for psychiatric disorders in relatives of schizophrenic and control probands: a comparison of three independent studies

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900236-5

7 January 2021

Schizotypal symptoms and signs in the Roscommon Family Study. Their factor structure and familial relationship with psychotic and affective disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900236-5

7 January 2021

Risperidone versus haloperidol on secondary memory: can newer medications aid learning?

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900236-5

7 January 2021

Diagnostic validity of basic symptoms.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900236-5

7 January 2021

Is schizophrenia a neurodegenerative disorder? A clinical and neurobiological perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900236-5

7 January 2021

Duration of psychosis and outcome in first-episode schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900236-5

7 January 2021

Early detection and intervention in schizophrenia: research

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900236-5

7 January 2021

Duration of untreated psychosis in first-episode schizophrenia: marker or determinant of course?

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900236-5

7 January 2021

The prevalence of prodromal features of schizophrenia in adolescence: a preliminary survey

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900236-5

7 January 2021

Early detection and treatment delay: implications for outcome in early psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900236-5

7 January 2021

Schizotaxia revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900236-5

7 January 2021

The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900236-5

7 January 2021

Symptom assessment in schizophrenic prodromal states

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900236-5

7 January 2021

The initial prodrome in schizophrenia: searching for naturalistic core dimensions of experience and behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900236-5

7 January 2021

Risk factors of psychosis: identifying vulnerable populations premorbidly

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900236-5

7 January 2021

Glutamate receptor dysfunction and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900236-5

7 January 2021

Increased morbid risk for schizophrenia-related disorders in relatives of schizotypal personality disordered patients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900236-5

7 January 2021

Towards the prevention of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900236-5

7 January 2021

Neuroleptics and the Natural Course of Schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900236-5

7 January 2021

The effects of early and sustained intervention on the long-term morbidity of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900236-5

7 January 2021

Long-term morbidity associated with delayed treatment of first admission schizophrenic patients: a re-analysis of the Camarillo State Hospital data

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900236-5

7 January 2021

The prodromal phase of first-episode psychosis: past and current conceptualizations

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900236-5

7 January 2021

The initial prodrome in psychosis: descriptive and qualitative aspects.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900236-5

7 January 2021

Vulnerability--a new view of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900236-5

7 January 2021

10.1016/S0920-9964(01)00236-5

Identifiers

DOI

1 reference

1 August 2017

1 reference